BR0014198A - Processo para o gerenciamento terapêutico da proliferação extra-uterina de tecido endometrial, dor pélvica crÈnica e obstrução da tuba de falópio - Google Patents
Processo para o gerenciamento terapêutico da proliferação extra-uterina de tecido endometrial, dor pélvica crÈnica e obstrução da tuba de falópioInfo
- Publication number
- BR0014198A BR0014198A BR0014198-4A BR0014198A BR0014198A BR 0014198 A BR0014198 A BR 0014198A BR 0014198 A BR0014198 A BR 0014198A BR 0014198 A BR0014198 A BR 0014198A
- Authority
- BR
- Brazil
- Prior art keywords
- pelvic pain
- chronic pelvic
- endometrial tissue
- extra
- therapeutic management
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15547899P | 1999-09-23 | 1999-09-23 | |
PCT/EP2000/009212 WO2001021194A2 (en) | 1999-09-23 | 2000-09-20 | Method for the therapeutic management of endometriosis and fallopian tube obstruction |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0014198A true BR0014198A (pt) | 2002-05-21 |
Family
ID=22555601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0014198-4A BR0014198A (pt) | 1999-09-23 | 2000-09-20 | Processo para o gerenciamento terapêutico da proliferação extra-uterina de tecido endometrial, dor pélvica crÈnica e obstrução da tuba de falópio |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1214086A2 (no) |
JP (2) | JP2003509467A (no) |
KR (1) | KR100772852B1 (no) |
CN (2) | CN1376070A (no) |
AU (1) | AU769482B2 (no) |
BG (1) | BG66128B1 (no) |
BR (1) | BR0014198A (no) |
CA (1) | CA2383510A1 (no) |
HK (1) | HK1049117A1 (no) |
HU (1) | HUP0202741A3 (no) |
IL (1) | IL148185A0 (no) |
MX (1) | MXPA02002436A (no) |
NO (1) | NO331198B1 (no) |
NZ (1) | NZ534836A (no) |
PL (1) | PL201898B1 (no) |
RU (1) | RU2255759C2 (no) |
SK (1) | SK3752002A3 (no) |
TR (1) | TR200200738T2 (no) |
TW (1) | TWI267373B (no) |
UA (1) | UA73956C2 (no) |
WO (1) | WO2001021194A2 (no) |
ZA (1) | ZA200201374B (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10157628A1 (de) * | 2001-11-26 | 2003-06-12 | Zentaris Ag | Injektionslösung eines LHRH-Antagonisten |
US7214662B2 (en) | 2001-11-27 | 2007-05-08 | Zentaris Gmbh | Injectable solution of an LHRH antagonist |
DK2252627T3 (en) | 2008-01-24 | 2017-08-14 | Esperance Pharmaceuticals | MERGER CONSTRUCTION WITH LYTIC DOMAIN AND METHOD FOR PRODUCING AND USING SAME. |
WO2010085145A1 (en) * | 2009-01-22 | 2010-07-29 | Maatschap Interne Geneeskunde Rijnstate | Method for the prophylaxis or treatment of flushing |
BR112015009752A2 (pt) | 2012-10-30 | 2017-07-11 | Esperance Pharmaceuticals Inc | conjugados de anticorpo/fármaco e métodos de uso |
EP4223298A3 (en) | 2013-03-15 | 2023-08-16 | AbbVie Inc. | Compositions for use in treating heavy menstrual bleeding |
BR112020021276A2 (pt) | 2018-04-19 | 2021-01-26 | Abbvie Inc. | métodos de tratamento de sangramento menstrual intenso |
EP3560555A1 (en) | 2018-04-26 | 2019-10-30 | LifeArc | A composition for treating one or more estrogen related diseases |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5064939A (en) * | 1990-02-06 | 1991-11-12 | The Salk Institute For Biological Studies | Cyclic gnrh antagonists |
SE9301606D0 (sv) * | 1993-05-07 | 1993-05-07 | Per-Christer Oden | Composition for the treatment of impaired hair growth |
US5658884A (en) * | 1994-07-22 | 1997-08-19 | The Medical College Of Hampton Roads | Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
EP0769956B1 (en) * | 1994-07-22 | 2000-03-15 | The Medical College Of Hampton Roads | USE OF A GnRH ANTAGONIST FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF GONADAL-STEROID CONDITIONS |
DE19513662A1 (de) * | 1995-04-08 | 1996-10-10 | Schering Ag | Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption |
DE19604231A1 (de) * | 1996-01-29 | 1997-07-31 | Schering Ag | Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen |
CN1228708A (zh) * | 1996-09-04 | 1999-09-15 | 有限会社多特 | 经口给药用含肽药物组合物 |
AU729752B2 (en) * | 1997-06-05 | 2001-02-08 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
DE19911771B4 (de) * | 1999-03-17 | 2006-03-30 | Zentaris Gmbh | LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung |
-
2000
- 2000-09-20 CA CA002383510A patent/CA2383510A1/en not_active Abandoned
- 2000-09-20 CN CN00813196A patent/CN1376070A/zh active Pending
- 2000-09-20 EP EP00967722A patent/EP1214086A2/en not_active Withdrawn
- 2000-09-20 PL PL353244A patent/PL201898B1/pl not_active IP Right Cessation
- 2000-09-20 KR KR1020027003740A patent/KR100772852B1/ko not_active IP Right Cessation
- 2000-09-20 WO PCT/EP2000/009212 patent/WO2001021194A2/en active IP Right Grant
- 2000-09-20 CN CNA2007100789192A patent/CN101045155A/zh active Pending
- 2000-09-20 JP JP2001524618A patent/JP2003509467A/ja not_active Withdrawn
- 2000-09-20 SK SK375-2002A patent/SK3752002A3/sk not_active Application Discontinuation
- 2000-09-20 NZ NZ534836A patent/NZ534836A/en not_active IP Right Cessation
- 2000-09-20 IL IL14818500A patent/IL148185A0/xx not_active IP Right Cessation
- 2000-09-20 HU HU0202741A patent/HUP0202741A3/hu unknown
- 2000-09-20 TR TR2002/00738T patent/TR200200738T2/xx unknown
- 2000-09-20 BR BR0014198-4A patent/BR0014198A/pt not_active Application Discontinuation
- 2000-09-20 RU RU2002111000/14A patent/RU2255759C2/ru not_active IP Right Cessation
- 2000-09-20 MX MXPA02002436A patent/MXPA02002436A/es active IP Right Grant
- 2000-09-20 UA UA2002043346A patent/UA73956C2/uk unknown
- 2000-09-20 AU AU77792/00A patent/AU769482B2/en not_active Ceased
- 2000-09-22 TW TW089119671A patent/TWI267373B/zh not_active IP Right Cessation
-
2002
- 2002-02-19 ZA ZA200201374A patent/ZA200201374B/en unknown
- 2002-03-21 NO NO20021430A patent/NO331198B1/no not_active IP Right Cessation
- 2002-04-05 BG BG106584A patent/BG66128B1/bg unknown
-
2003
- 2003-02-18 HK HK03101215.4A patent/HK1049117A1/zh unknown
-
2011
- 2011-10-17 JP JP2011227603A patent/JP2012051920A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
NO20021430L (no) | 2002-05-07 |
JP2003509467A (ja) | 2003-03-11 |
JP2012051920A (ja) | 2012-03-15 |
SK3752002A3 (en) | 2003-06-03 |
IL148185A0 (en) | 2002-09-12 |
BG106584A (bg) | 2003-02-28 |
NO331198B1 (no) | 2011-10-31 |
PL353244A1 (en) | 2003-11-03 |
RU2255759C2 (ru) | 2005-07-10 |
ZA200201374B (en) | 2002-10-30 |
NZ534836A (en) | 2007-07-27 |
PL201898B1 (pl) | 2009-05-29 |
KR100772852B1 (ko) | 2007-11-02 |
TR200200738T2 (tr) | 2002-08-21 |
NO20021430D0 (no) | 2002-03-21 |
HUP0202741A3 (en) | 2003-12-29 |
CA2383510A1 (en) | 2001-03-29 |
WO2001021194A2 (en) | 2001-03-29 |
MXPA02002436A (es) | 2003-02-12 |
BG66128B1 (bg) | 2011-06-30 |
HK1049117A1 (zh) | 2003-05-02 |
UA73956C2 (en) | 2005-10-17 |
TWI267373B (en) | 2006-12-01 |
AU7779200A (en) | 2001-04-24 |
AU769482B2 (en) | 2004-01-29 |
EP1214086A2 (en) | 2002-06-19 |
WO2001021194A3 (en) | 2002-03-14 |
CN101045155A (zh) | 2007-10-03 |
CN1376070A (zh) | 2002-10-23 |
KR20020035879A (ko) | 2002-05-15 |
HUP0202741A2 (hu) | 2003-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Horlocker et al. | Analgesia for total hip and knee arthroplasty: a multimodal pathway featuring peripheral nerve block | |
BR0110914A (pt) | Composição farmacêutica lìquida, conjugado, processo para preparação e utilização de uma composição, processo para o tratamento e prevenção de enfermidades que envolvem anemia e dispositivo para liberação local e sistêmica sustentada de uma composicão | |
BR0115109A (pt) | Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese | |
BR0015974A (pt) | Uso de levetiracetam, composição farmacêutica, uso de uma composição farmacêutica e métodos para tratar um paciente admintstrado com uma quantidade de pelo menos um composto e uma doença e para potenciar seletivamente o efeito terapêutico de um composto | |
BRPI0407485A (pt) | utilização de anticorpos anti-receptores de factor crescimento i semelhantes aos anti-insulina | |
BR0308250A (pt) | Métodos de indução de diferenciação terminal | |
BRPI0314308B8 (pt) | antagonistas de opióide, seus usos, e composição farmacêutica | |
RU2001118040A (ru) | Композиция контролированного высвобождения, включающая gnrh-ii | |
ATE360630T1 (de) | Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors | |
BR0111207A (pt) | Combinações de um antagonista receptor de endotelina e um composto antiepiléptico tendo propriedades de alìvio da dor ou analgésicos | |
ES2295609T3 (es) | Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor. | |
BRPI0412493A (pt) | métodos de tratamento hormonal utilizando regimes contraceptivos com administração contìnua de estrogênio | |
BR0112661A (pt) | Nova combinação de agonista (5ht2) e antagonista (5ht6) da serotonina como formulação farmacêutica | |
BRPI0400214A (pt) | Composições e aplicações farmacêuticas para a obtenção confiável de nìveis aceitáveis de testosterona no soro | |
BR9914419A (pt) | Terapia para melhoria da percepção | |
BR0014198A (pt) | Processo para o gerenciamento terapêutico da proliferação extra-uterina de tecido endometrial, dor pélvica crÈnica e obstrução da tuba de falópio | |
JP2001510795A5 (no) | ||
Adachi et al. | Physical characteristics, pharmacological properties and clinical efficacy of the ketoprofen patch: a new patch formulation. | |
BR0214075A (pt) | Dosagem unitária que compreende um análogo de prostaglandina para tratar constipação | |
BR0200246A (pt) | Tratamento de combinação para a depressão | |
BR0201974A (pt) | Composição farmacêutica para tratamento de alterações do sono | |
BR0014979A (pt) | Composição hormonal e sua utilização | |
BR0008057A (pt) | Forma cristalina de eplerenona apresentando velocidade de dissolução intensificada | |
BR0206819A (pt) | Uso de inibidores de il-18 para o tratamento e/ou para a prevenção de doença cardìaca | |
RU2010107177A (ru) | Новые комбинации нерамексана для лечения нейродегенеративных расстройств |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: BLITZ F02-570 GMBH (DE) Free format text: TRANSFERIDO POR FUSAO DE: ZENTARIS AG |
|
B25D | Requested change of name of applicant approved |
Owner name: ZENTARIS GMBH (DE) Free format text: ALTERADO DE: BLITZ F02-570 GMBH |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 13, 25 E 10 (VIII) DA LPI. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |